Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

PURPOSE: Anaplastic thyroid carcinoma (ATC) is one of the most lethal human cancers with a median survival of 6 months. The inhibition of epidermal growth factor receptor (EGFR) alone, or with vascular endothelial growth factor receptor2 (VEGFR2), represents an attractive approach for treatment of A...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gule, Maria K., Chen, Yunyun, Sano, Daisuke, Frederick, Mitchell J., Zhou, Ge, Zhao, Mei, Milas, Zvonimir L., Galer, Chad E., Henderson, Ying C., Jasser, Samar A., Schwartz, David L., Bankson, James A., Myers, Jeffrey N., Lai, Stephen Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079006/
https://ncbi.nlm.nih.gov/pubmed/21220477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2762
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller